Table 3 Comparison of short-term effects in patients with different subtypes of lung cancer in the test group
Project | CR | PR | SD | PD | ORR | DCR |
|---|---|---|---|---|---|---|
SCLC (n = 44) | 9 (20.5) | 12 (27.3) | 14 (31.8) | 9 (20.4) | 47.8 | 78.9 |
NSCLC (n = 164) | 99 (60.4) | 30 (18.3) | 26 (15.8) | 9 (5.5) | 78.7 | 94.5 |
P Value | < 0.0001 | 0.002 | ||||
LADC (n = 109) | 70 (64.2) | 19 (17.4) | 15 (13.8) | 5 (4.6) | 81.6 | 95.4 |
LSCC (n = 55) | 29 (52.7) | 11 (20) | 11 (20) | 4 (7.3) | 72.7 | 92.7 |
P Value | 0.13 | 0.55 |